> top > docs > PMC:3291650 > spans > 33398-34365 > annotations

PMC:3291650 / 33398-34365 JSONTXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T15462 965-966 -RRB- denotes ]
T15461 963-965 CD denotes 85
T15460 962-963 -LRB- denotes [
T15459 955-961 NNP denotes Muench
T15458 951-954 CC denotes and
T15457 946-950 NNP denotes Reed
T15456 943-945 IN denotes of
T15455 936-942 NN denotes method
T15454 932-935 DT denotes the
T15453 929-931 TO denotes to
T15452 919-928 VB denotes according
T15451 908-918 VB denotes calculated
T15450 903-907 RB denotes then
T15449 898-902 VB denotes were
T15448 891-897 NN denotes titers
T15447 884-890 NN denotes TCID50
T15446 873-882 VB denotes monitored
T15445 869-872 VB denotes was
T15444 852-868 NN denotes hemagglutination
T15443 849-851 IN denotes of
T15442 840-848 NN denotes dilution
T15441 830-839 JJ denotes end-point
T15440 826-829 CC denotes and
T15439 820-825 VB denotes added
T15438 815-819 VB denotes were
T15437 813-814 -RRB- denotes )
T15436 810-813 NN denotes RBC
T15435 809-810 -LRB- denotes (
T15434 803-808 NN denotes cells
T15433 797-802 NN denotes blood
T15432 793-796 JJ denotes red
T15431 785-792 NN denotes chicken
T15430 783-784 NN denotes %
T15429 780-783 CD denotes 0.5
T15428 778-779 -COMMA- denotes ,
T15427 770-778 NN denotes read-out
T15426 766-769 IN denotes For
T15425 753-764 NN denotes antibiotics
T15424 749-752 CC denotes and
T15423 740-748 NN denotes pyruvate
T15422 733-739 NN denotes sodium
T15421 730-732 NN denotes mM
T15420 726-729 CD denotes 0.4
T15419 724-725 -COMMA- denotes ,
T15418 713-724 NN denotes L-glutamine
T15417 710-712 NN denotes mM
T15416 708-709 CD denotes 2
T15415 706-707 -COMMA- denotes ,
T15414 705-706 -RRB- denotes )
T15413 700-705 NN denotes µg/ml
T15412 698-699 CD denotes 1
T15411 697-698 -LRB- denotes (
T15410 689-696 NN denotes trypsin
T15409 684-688 IN denotes with
T15408 671-683 VB denotes supplemented
T15407 666-670 NN denotes DMEM
T15406 663-665 IN denotes in
T15405 658-662 NN denotes days
T15404 656-657 CD denotes 5
T15403 652-655 IN denotes for
T15402 646-651 NN denotes cells
T15401 641-645 NN denotes MDCK
T15400 638-640 IN denotes on
T15399 628-637 VB denotes incubated
T15398 623-627 VB denotes were
T15397 611-622 NN denotes homogenates
T15396 606-610 NN denotes lung
T15395 603-605 IN denotes of
T15394 593-602 NN denotes dilutions
T15393 586-592 JJ denotes serial
T15392 575-585 JJ denotes Eight-fold
T15391 570-573 NNP denotes PBS
T15390 567-569 IN denotes in
T15389 565-566 -RRB- denotes )
T15388 555-565 NN denotes Kinematica
T15387 554-555 -LRB- denotes (
T15386 542-553 NN denotes homogenizer
T15385 533-541 NN denotes Polytron
T15384 531-532 DT denotes a
T15383 526-530 IN denotes with
T15382 514-525 VB denotes homogenized
T15381 509-513 VB denotes were
T15380 503-508 NN denotes lungs
T15379 501-502 -COLON- denotes :
T15378 494-501 VB denotes follows
T15377 491-493 IN denotes as
T15376 482-490 VB denotes measured
T15375 478-481 VB denotes was
T15374 476-477 -RRB- denotes )
T15373 470-476 NN denotes TCID50
T15372 469-470 -LRB- denotes (
T15371 464-468 NN denotes dose
T15370 453-463 JJ denotes infectious
T15369 445-452 NN denotes culture
T15368 438-444 NN denotes tissue
T15367 431-437 JJ denotes median
T15366 429-430 -COMMA- denotes ,
T15365 423-429 NN denotes titers
T15364 417-422 JJ denotes viral
T15363 407-416 JJ denotes pulmonary
T15362 397-406 VB denotes determine
T15361 394-396 TO denotes To
T15360 388-392 NN denotes X-47
T15330 213-218 NN denotes mg/kg
T15329 210-212 CD denotes 12
T15328 209-210 -LRB- denotes (
T15327 200-208 NN denotes ketamine
T15326 195-199 IN denotes with
T15325 185-194 NN denotes injection
T15324 180-184 JJ denotes i.p.
T15323 177-179 IN denotes by
T15322 164-176 VB denotes anesthetized
T15321 159-163 VB denotes were
T15320 154-158 NN denotes mice
T15319 152-153 -COMMA- denotes ,
T15318 141-152 NN denotes inoculation
T15317 135-140 JJ denotes viral
T15316 131-134 IN denotes For
T15315 124-129 NN denotes cells
T15314 119-123 NN denotes MDCK
T15313 116-118 IN denotes in
T15312 105-115 VB denotes propagated
T15311 101-104 VB denotes was
T15310 99-100 -RRB- denotes )
T15309 80-99 NN denotes PR8×A/Victoria/3/75
T15308 78-79 -COLON- denotes ;
T15307 74-78 NN denotes H3N2
T15306 73-74 -LRB- denotes (
T15305 68-72 NN denotes X-47
T15304 64-67 NN denotes IAV
T15303 56-63 VB denotes adapted
T15302 50-55 NN denotes Mouse
T15301 43-49 NN denotes titers
T15300 37-42 JJ denotes viral
T15299 34-36 IN denotes of
T15298 20-33 NN denotes determination
T15297 16-19 CC denotes and
T15296 6-15 NN denotes infection
T15295 0-5 JJ denotes Viral
T15359 378-387 CD denotes 0.05-LD50
T15358 375-377 CC denotes or
T15357 368-374 NN denotes 2-LD50
T15356 355-367 RB denotes respectively
T15355 346-354 VB denotes received
T15354 341-345 NN denotes mice
T15353 339-340 -COMMA- denotes ,
T15352 330-339 NN denotes infection
T15351 320-329 JJ denotes sublethal
T15350 316-319 CC denotes and
T15349 309-315 JJ denotes lethal
T15348 305-308 IN denotes For
T15347 291-303 RB denotes intranasally
T15346 278-290 VB denotes administered
T15345 274-277 VB denotes was
T15344 270-273 NNP denotes PBS
T15343 267-269 IN denotes in
T15342 259-266 VB denotes diluted
T15341 254-258 NN denotes X-47
T15340 251-253 NN denotes µl
T15339 248-250 CD denotes 50
T15338 244-247 CC denotes and
T15337 242-243 -RRB- denotes )
T15336 237-242 NN denotes mg/kg
T15335 234-236 CD denotes 60
T15334 233-234 -LRB- denotes (
T15333 224-232 NN denotes xylazine
T15332 220-223 CC denotes and
T15331 218-219 -RRB- denotes )
R11393 T15296 T15295 arg1Of infection,Viral
R11394 T15296 T15297 arg1Of infection,and
R11395 T15297 T15299 arg1Of and,of
R11396 T15298 T15297 arg2Of determination,and
R11397 T15301 T15299 arg2Of titers,of
R11398 T15301 T15300 arg1Of titers,viral
R11399 T15302 T15303 arg1Of Mouse,adapted
R11400 T15305 T15304 arg1Of X-47,IAV
R11401 T15305 T15306 arg1Of X-47,(
R11402 T15305 T15311 arg1Of X-47,was
R11403 T15305 T15312 arg2Of X-47,propagated
R11404 T15307 T15306 arg2Of H3N2,(
R11405 T15307 T15308 arg1Of H3N2,;
R11406 T15309 T15308 arg2Of PR8×A/Victoria/3/75,;
R11407 T15310 T15306 arg3Of ),(
R11408 T15312 T15303 arg2Of propagated,adapted
R11409 T15312 T15311 arg2Of propagated,was
R11410 T15312 T15313 arg1Of propagated,in
R11411 T15315 T15313 arg2Of cells,in
R11412 T15315 T15314 arg1Of cells,MDCK
R11413 T15318 T15316 arg2Of inoculation,For
R11414 T15318 T15317 arg1Of inoculation,viral
R11415 T15320 T15321 arg1Of mice,were
R11416 T15320 T15322 arg2Of mice,anesthetized
R11417 T15322 T15316 arg1Of anesthetized,For
R11418 T15322 T15319 arg1Of anesthetized,","
R11419 T15322 T15321 arg2Of anesthetized,were
R11420 T15325 T15322 arg1Of injection,anesthetized
R11421 T15325 T15323 arg2Of injection,by
R11422 T15325 T15324 arg1Of injection,i.p.
R11423 T15325 T15326 arg1Of injection,with
R11424 T15327 T15328 arg1Of ketamine,(
R11425 T15327 T15332 arg1Of ketamine,and
R11426 T15330 T15328 arg2Of mg/kg,(
R11427 T15330 T15329 arg1Of mg/kg,12
R11428 T15331 T15328 arg3Of ),(
R11429 T15332 T15338 arg1Of and,and
R11430 T15333 T15332 arg2Of xylazine,and
R11431 T15333 T15334 arg1Of xylazine,(
R11432 T15336 T15334 arg2Of mg/kg,(
R11433 T15336 T15335 arg1Of mg/kg,60
R11434 T15337 T15334 arg3Of ),(
R11435 T15338 T15326 arg2Of and,with
R11436 T15341 T15338 arg2Of X-47,and
R11437 T15341 T15339 arg1Of X-47,50
R11438 T15341 T15340 arg1Of X-47,µl
R11439 T15341 T15342 arg2Of X-47,diluted
R11440 T15342 T15343 arg1Of diluted,in
R11441 T15344 T15345 arg1Of PBS,was
R11442 T15344 T15346 arg2Of PBS,administered
R11443 T15346 T15343 arg2Of administered,in
R11444 T15346 T15345 arg2Of administered,was
R11445 T15346 T15347 arg1Of administered,intranasally
R11446 T15349 T15350 arg1Of lethal,and
R11447 T15351 T15350 arg2Of sublethal,and
R11448 T15352 T15348 arg2Of infection,For
R11449 T15352 T15349 arg1Of infection,lethal
R11450 T15352 T15351 arg1Of infection,sublethal
R11451 T15354 T15355 arg1Of mice,received
R11452 T15355 T15348 arg1Of received,For
R11453 T15355 T15353 arg1Of received,","
R11454 T15355 T15356 arg1Of received,respectively
R11455 T15357 T15358 arg1Of 2-LD50,or
R11456 T15358 T15355 arg2Of or,received
R11457 T15360 T15358 arg2Of X-47,or
R11458 T15360 T15359 arg1Of X-47,0.05-LD50
R11459 T15362 T15361 arg1Of determine,To
R11460 T15365 T15362 arg2Of titers,determine
R11461 T15365 T15363 arg1Of titers,pulmonary
R11462 T15365 T15364 arg1Of titers,viral
R11463 T15371 T15362 arg1Of dose,determine
R11464 T15371 T15367 arg1Of dose,median
R11465 T15371 T15368 arg1Of dose,tissue
R11466 T15371 T15369 arg1Of dose,culture
R11467 T15371 T15370 arg1Of dose,infectious
R11468 T15371 T15372 arg1Of dose,(
R11469 T15371 T15375 arg1Of dose,was
R11470 T15371 T15376 arg2Of dose,measured
R11471 T15371 T15378 arg1Of dose,follows
R11472 T15373 T15372 arg2Of TCID50,(
R11473 T15374 T15372 arg3Of ),(
R11474 T15376 T15375 arg2Of measured,was
R11475 T15376 T15377 arg1Of measured,as
R11476 T15377 T15361 modOf as,To
R11477 T15377 T15366 arg1Of as,","
R11478 T15378 T15377 arg2Of follows,as
R11479 T15378 T15379 arg1Of follows,:
R11480 T15380 T15381 arg1Of lungs,were
R11481 T15380 T15382 arg2Of lungs,homogenized
R11482 T15382 T15379 arg2Of homogenized,:
R11483 T15382 T15381 arg2Of homogenized,were
R11484 T15382 T15383 arg1Of homogenized,with
R11485 T15386 T15383 arg2Of homogenizer,with
R11486 T15386 T15384 arg1Of homogenizer,a
R11487 T15386 T15385 arg1Of homogenizer,Polytron
R11488 T15386 T15387 arg1Of homogenizer,(
R11489 T15386 T15390 arg1Of homogenizer,in
R11490 T15388 T15387 arg2Of Kinematica,(
R11491 T15389 T15387 arg3Of ),(
R11492 T15391 T15390 arg2Of PBS,in
R11493 T15394 T15392 arg1Of dilutions,Eight-fold
R11494 T15394 T15393 arg1Of dilutions,serial
R11495 T15394 T15395 arg1Of dilutions,of
R11496 T15394 T15398 arg1Of dilutions,were
R11497 T15394 T15399 arg2Of dilutions,incubated
R11498 T15397 T15395 arg2Of homogenates,of
R11499 T15397 T15396 arg1Of homogenates,lung
R11500 T15399 T15398 arg2Of incubated,were
R11501 T15399 T15400 arg1Of incubated,on
R11502 T15402 T15400 arg2Of cells,on
R11503 T15402 T15401 arg1Of cells,MDCK
R11504 T15402 T15403 arg1Of cells,for
R11505 T15405 T15403 arg2Of days,for
R11506 T15405 T15404 arg1Of days,5
R11507 T15405 T15406 arg1Of days,in
R11508 T15405 T15408 arg2Of days,supplemented
R11509 T15407 T15406 arg2Of DMEM,in
R11510 T15408 T15409 arg1Of supplemented,with
R11511 T15410 T15411 arg1Of trypsin,(
R11512 T15410 T15415 arg1Of trypsin,","
R11513 T15413 T15411 arg2Of µg/ml,(
R11514 T15413 T15412 arg1Of µg/ml,1
R11515 T15414 T15411 arg3Of ),(
R11516 T15415 T15419 arg1Of ",",","
R11517 T15416 T15417 arg1Of 2,mM
R11518 T15418 T15415 arg2Of L-glutamine,","
R11519 T15418 T15416 arg1Of L-glutamine,2
R11520 T15419 T15424 arg1Of ",",and
R11521 T15420 T15421 arg1Of 0.4,mM
R11522 T15423 T15419 arg2Of pyruvate,","
R11523 T15423 T15420 arg1Of pyruvate,0.4
R11524 T15423 T15422 arg1Of pyruvate,sodium
R11525 T15424 T15409 arg2Of and,with
R11526 T15425 T15424 arg2Of antibiotics,and
R11527 T15427 T15426 arg2Of read-out,For
R11528 T15429 T15430 arg1Of 0.5,%
R11529 T15434 T15429 arg1Of cells,0.5
R11530 T15434 T15431 arg1Of cells,chicken
R11531 T15434 T15432 arg1Of cells,red
R11532 T15434 T15433 arg1Of cells,blood
R11533 T15434 T15435 arg1Of cells,(
R11534 T15434 T15438 arg1Of cells,were
R11535 T15434 T15439 arg2Of cells,added
R11536 T15436 T15435 arg2Of RBC,(
R11537 T15437 T15435 arg3Of ),(
R11538 T15439 T15438 arg2Of added,were
R11539 T15439 T15440 arg1Of added,and
R11540 T15440 T15426 arg1Of and,For
R11541 T15440 T15428 arg1Of and,","
R11542 T15442 T15441 arg1Of dilution,end-point
R11543 T15442 T15443 arg1Of dilution,of
R11544 T15442 T15445 arg1Of dilution,was
R11545 T15442 T15446 arg2Of dilution,monitored
R11546 T15444 T15443 arg2Of hemagglutination,of
R11547 T15446 T15440 arg2Of monitored,and
R11548 T15446 T15445 arg2Of monitored,was
R11549 T15448 T15447 arg1Of titers,TCID50
R11550 T15448 T15449 arg1Of titers,were
R11551 T15448 T15451 arg2Of titers,calculated
R11552 T15451 T15449 arg2Of calculated,were
R11553 T15451 T15450 arg1Of calculated,then
R11554 T15451 T15452 arg1Of calculated,according
R11555 T15453 T15452 arg2Of to,according
R11556 T15455 T15453 arg2Of method,to
R11557 T15455 T15454 arg1Of method,the
R11558 T15455 T15456 arg1Of method,of
R11559 T15457 T15458 arg1Of Reed,and
R11560 T15458 T15456 arg2Of and,of
R11561 T15459 T15458 arg2Of Muench,and
R11562 T15459 T15460 arg1Of Muench,[
R11563 T15461 T15460 arg2Of 85,[
R11564 T15462 T15460 arg3Of ],[

UBERON-AE

Id Subject Object Predicate Lexical cue
T15281 797-802 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T15280 606-610 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T15279 503-508 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lungs
T15278 438-444 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue

GO-BP

Id Subject Object Predicate Lexical cue
T15290 0-15 http://purl.obolibrary.org/obo/GO_0016032 denotes Viral infection

GO-CC

Id Subject Object Predicate Lexical cue
T15294 803-808 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T15293 646-651 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T15292 124-129 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

sentences

Id Subject Object Predicate Lexical cue
T15289 884-967 Sentence denotes TCID50 titers were then calculated according to the method of Reed and Muench [85].
T15288 766-883 Sentence denotes For read-out, 0.5% chicken red blood cells (RBC) were added and end-point dilution of hemagglutination was monitored.
T15287 575-765 Sentence denotes Eight-fold serial dilutions of lung homogenates were incubated on MDCK cells for 5 days in DMEM supplemented with trypsin (1 µg/ml), 2 mM L-glutamine, 0.4 mM sodium pyruvate and antibiotics.
T15286 394-574 Sentence denotes To determine pulmonary viral titers, median tissue culture infectious dose (TCID50) was measured as follows: lungs were homogenized with a Polytron homogenizer (Kinematica) in PBS.
T15285 305-393 Sentence denotes For lethal and sublethal infection, mice received respectively 2-LD50 or 0.05-LD50 X-47.
T15284 131-304 Sentence denotes For viral inoculation, mice were anesthetized by i.p. injection with ketamine (12 mg/kg) and xylazine (60 mg/kg) and 50 µl X-47 diluted in PBS was administered intranasally.
T15283 50-130 Sentence denotes Mouse adapted IAV X-47 (H3N2; PR8×A/Victoria/3/75) was propagated in MDCK cells.
T15282 0-49 Sentence denotes Viral infection and determination of viral titers
T209 0-49 Sentence denotes Viral infection and determination of viral titers
T210 50-130 Sentence denotes Mouse adapted IAV X-47 (H3N2; PR8×A/Victoria/3/75) was propagated in MDCK cells.
T211 131-304 Sentence denotes For viral inoculation, mice were anesthetized by i.p. injection with ketamine (12 mg/kg) and xylazine (60 mg/kg) and 50 µl X-47 diluted in PBS was administered intranasally.
T212 305-393 Sentence denotes For lethal and sublethal infection, mice received respectively 2-LD50 or 0.05-LD50 X-47.
T213 394-574 Sentence denotes To determine pulmonary viral titers, median tissue culture infectious dose (TCID50) was measured as follows: lungs were homogenized with a Polytron homogenizer (Kinematica) in PBS.
T214 575-765 Sentence denotes Eight-fold serial dilutions of lung homogenates were incubated on MDCK cells for 5 days in DMEM supplemented with trypsin (1 µg/ml), 2 mM L-glutamine, 0.4 mM sodium pyruvate and antibiotics.
T215 766-883 Sentence denotes For read-out, 0.5% chicken red blood cells (RBC) were added and end-point dilution of hemagglutination was monitored.
T216 884-967 Sentence denotes TCID50 titers were then calculated according to the method of Reed and Muench [85].

ICD10

Id Subject Object Predicate Lexical cue
T15291 0-15 http://purl.bioontology.org/ontology/ICD10/B34.9 denotes Viral infection

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T15656 641-696 Entity denotes MDCK cells for 5 days in DMEM supplemented with trypsin
T15655 708-724 Entity denotes 2 mM L-glutamine
T15654 726-748 Entity denotes 0.4 mM sodium pyruvate
T15653 780-814 Entity denotes 0.5% chicken red blood cells (RBC)
T15652 810-813 Entity denotes RBC
T15651 154-158 Protein denotes mice
T15650 689-696 Entity denotes trypsin
T15649 341-345 Protein denotes mice
T15648 200-219 Entity denotes ketamine (12 mg/kg)

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T15575 628-637 VBN denotes incubated
T15574 623-627 VBD denotes were
T15573 611-622 NNS denotes homogenates
T15572 606-610 NN denotes lung
T15571 603-605 IN denotes of
T15570 593-602 NNS denotes dilutions
T15569 586-592 JJ denotes serial
T15568 575-585 JJ denotes Eight-fold
T15567 573-574 . denotes .
T15566 570-573 NNP denotes PBS
T15565 567-569 IN denotes in
T15564 565-566 -RRB- denotes )
T15563 555-565 NNP denotes Kinematica
T15562 554-555 -LRB- denotes (
T15561 542-553 NN denotes homogenizer
T15560 533-541 NNP denotes Polytron
T15559 531-532 DT denotes a
T15558 526-530 IN denotes with
T15557 514-525 VBN denotes homogenized
T15556 509-513 VBD denotes were
T15555 503-508 NNS denotes lungs
T15554 501-502 : denotes :
T15553 494-501 VBZ denotes follows
T15552 491-493 IN denotes as
T15551 482-490 VBN denotes measured
T15550 478-481 VBD denotes was
T15549 476-477 -RRB- denotes )
T15548 470-476 CD denotes TCID50
T15547 469-470 -LRB- denotes (
T15546 464-468 NN denotes dose
T15545 453-463 JJ denotes infectious
T15544 445-452 NN denotes culture
T15543 438-444 NN denotes tissue
T15542 431-437 JJ denotes median
T15504 218-219 -RRB- denotes )
T15503 213-218 NN denotes mg/kg
T15502 210-212 CD denotes 12
T15501 209-210 -LRB- denotes (
T15500 200-208 NN denotes ketamine
T15499 195-199 IN denotes with
T15498 185-194 NN denotes injection
T15497 180-184 JJ denotes i.p.
T15496 177-179 IN denotes by
T15495 164-176 JJ denotes anesthetized
T15494 159-163 VBD denotes were
T15493 154-158 NNS denotes mice
T15492 152-153 , denotes ,
T15491 141-152 NN denotes inoculation
T15490 135-140 JJ denotes viral
T15489 131-134 IN denotes For
T15488 129-130 . denotes .
T15487 124-129 NNS denotes cells
T15486 119-123 NNP denotes MDCK
T15485 116-118 IN denotes in
T15643 966-967 . denotes .
T15642 965-966 NNP denotes ]
T15641 963-965 CD denotes 85
T15640 962-963 NNP denotes [
T15639 955-961 NNP denotes Muench
T15638 951-954 CC denotes and
T15637 946-950 NNP denotes Reed
T15636 943-945 IN denotes of
T15635 936-942 NN denotes method
T15634 932-935 DT denotes the
T15633 929-931 TO denotes to
T15632 919-928 VBG denotes according
T15631 908-918 VBN denotes calculated
T15630 903-907 RB denotes then
T15629 898-902 VBD denotes were
T15628 891-897 NNS denotes titers
T15627 884-890 CD denotes TCID50
T15626 882-883 . denotes .
T15625 873-882 VBN denotes monitored
T15624 869-872 VBD denotes was
T15623 852-868 NN denotes hemagglutination
T15622 849-851 IN denotes of
T15621 840-848 NN denotes dilution
T15620 830-839 JJ denotes end-point
T15619 826-829 CC denotes and
T15618 820-825 VBN denotes added
T15617 815-819 VBD denotes were
T15616 813-814 -RRB- denotes )
T15615 810-813 NNP denotes RBC
T15614 809-810 -LRB- denotes (
T15613 803-808 NNS denotes cells
T15612 797-802 NN denotes blood
T15611 793-796 JJ denotes red
T15610 785-792 NN denotes chicken
T15609 783-784 NN denotes %
T15608 780-783 CD denotes 0.5
T15607 778-779 , denotes ,
T15606 770-778 JJ denotes read-out
T15605 766-769 IN denotes For
T15604 764-765 . denotes .
T15603 753-764 NNS denotes antibiotics
T15602 749-752 CC denotes and
T15601 740-748 NN denotes pyruvate
T15600 733-739 NN denotes sodium
T15599 730-732 NNP denotes mM
T15598 726-729 CD denotes 0.4
T15597 724-725 , denotes ,
T15596 713-724 NNP denotes L-glutamine
T15595 710-712 NNP denotes mM
T15594 708-709 CD denotes 2
T15593 706-707 , denotes ,
T15592 705-706 -RRB- denotes )
T15591 703-705 NN denotes ml
T15590 702-703 NN denotes /
T15589 700-702 NN denotes µg
T15588 698-699 CD denotes 1
T15587 697-698 -LRB- denotes (
T15586 689-696 NN denotes trypsin
T15585 684-688 IN denotes with
T15584 671-683 VBN denotes supplemented
T15583 666-670 NNP denotes DMEM
T15582 663-665 IN denotes in
T15581 658-662 NNS denotes days
T15580 656-657 CD denotes 5
T15579 652-655 IN denotes for
T15578 646-651 NNS denotes cells
T15577 641-645 NNP denotes MDCK
T15576 638-640 IN denotes on
T15522 305-308 IN denotes For
T15521 303-304 . denotes .
T15520 291-303 RB denotes intranasally
T15519 278-290 VBN denotes administered
T15518 274-277 VBD denotes was
T15484 105-115 VBN denotes propagated
T15483 101-104 VBD denotes was
T15482 99-100 -RRB- denotes )
T15481 97-99 CD denotes 75
T15480 96-97 VBD denotes /
T15479 84-96 NNP denotes A/Victoria/3
T15478 83-84 NNP denotes ×
T15477 80-83 NNP denotes PR8
T15476 78-79 : denotes ;
T15475 74-78 NNP denotes H3N2
T15474 73-74 -LRB- denotes (
T15473 68-72 NNP denotes X-47
T15472 64-67 NNP denotes IAV
T15471 56-63 VBD denotes adapted
T15470 50-55 NNP denotes Mouse
T15469 43-49 NNS denotes titers
T15468 37-42 JJ denotes viral
T15467 34-36 IN denotes of
T15466 20-33 NN denotes determination
T15465 16-19 CC denotes and
T15464 6-15 NN denotes infection
T15463 0-5 JJ denotes Viral
T15541 429-430 , denotes ,
T15540 423-429 NNS denotes titers
T15539 417-422 JJ denotes viral
T15538 407-416 JJ denotes pulmonary
T15537 397-406 VB denotes determine
T15536 394-396 TO denotes To
T15535 392-393 . denotes .
T15534 388-392 NNP denotes X-47
T15533 378-387 JJ denotes 0.05-LD50
T15532 375-377 CC denotes or
T15531 368-374 JJ denotes 2-LD50
T15530 355-367 RB denotes respectively
T15529 346-354 VBD denotes received
T15528 341-345 NNS denotes mice
T15527 339-340 , denotes ,
T15526 330-339 NN denotes infection
T15525 320-329 JJ denotes sublethal
T15524 316-319 CC denotes and
T15523 309-315 JJ denotes lethal
T15517 270-273 NNP denotes PBS
T15516 267-269 IN denotes in
T15515 259-266 VBN denotes diluted
T15514 254-258 NNP denotes X-47
T15513 251-253 NN denotes µl
T15512 248-250 CD denotes 50
T15511 244-247 CC denotes and
T15510 242-243 -RRB- denotes )
T15509 237-242 NN denotes mg/kg
T15508 234-236 CD denotes 60
T15507 233-234 -LRB- denotes (
T15506 224-232 NN denotes xylazine
T15505 220-223 CC denotes and
R11578 T15476 T15473 punct ;,X-47
R11579 T15477 T15479 compound PR8,A/Victoria/3
R11580 T15478 T15479 compound ×,A/Victoria/3
R11581 T15479 T15480 nsubj A/Victoria/3,/
R11582 T15480 T15471 parataxis /,adapted
R11583 T15481 T15480 npadvmod 75,/
R11584 T15482 T15480 punct ),/
R11585 T15483 T15484 auxpass was,propagated
R11586 T15484 T15471 conj propagated,adapted
R11587 T15485 T15484 prep in,propagated
R11588 T15486 T15487 compound MDCK,cells
R11589 T15487 T15485 pobj cells,in
R11590 T15488 T15471 punct .,adapted
R11591 T15489 T15495 prep For,anesthetized
R11592 T15490 T15491 amod viral,inoculation
R11593 T15491 T15489 pobj inoculation,For
R11594 T15492 T15495 punct ",",anesthetized
R11595 T15493 T15495 nsubjpass mice,anesthetized
R11596 T15494 T15495 auxpass were,anesthetized
R11597 T15495 T15495 ROOT anesthetized,anesthetized
R11598 T15496 T15495 agent by,anesthetized
R11599 T15497 T15498 amod i.p.,injection
R11600 T15498 T15514 nmod injection,X-47
R11601 T15499 T15498 prep with,injection
R11602 T15500 T15499 pobj ketamine,with
R11603 T15501 T15503 punct (,mg/kg
R11604 T15502 T15503 nummod 12,mg/kg
R11605 T15503 T15514 nmod mg/kg,X-47
R11606 T15504 T15503 punct ),mg/kg
R11607 T15505 T15503 cc and,mg/kg
R11608 T15506 T15503 conj xylazine,mg/kg
R11609 T15507 T15506 punct (,xylazine
R11610 T15508 T15509 nummod 60,mg/kg
R11611 T15509 T15506 appos mg/kg,xylazine
R11612 T15510 T15509 punct ),mg/kg
R11613 T15511 T15506 cc and,xylazine
R11614 T15512 T15513 nummod 50,µl
R11615 T15513 T15514 compound µl,X-47
R11616 T15514 T15496 pobj X-47,by
R11617 T15515 T15514 amod diluted,X-47
R11618 T15516 T15515 prep in,diluted
R11619 T15517 T15516 pobj PBS,in
R11620 T15518 T15519 auxpass was,administered
R11621 T15519 T15495 conj administered,anesthetized
R11622 T15520 T15519 advmod intranasally,administered
R11623 T15521 T15519 punct .,administered
R11624 T15522 T15529 prep For,received
R11625 T15523 T15526 amod lethal,infection
R11652 T15550 T15551 auxpass was,measured
R11653 T15551 T15557 ccomp measured,homogenized
R11654 T15552 T15553 mark as,follows
R11655 T15553 T15551 advcl follows,measured
R11656 T15554 T15557 punct :,homogenized
R11657 T15555 T15556 nsubj lungs,were
R11658 T15556 T15557 auxpass were,homogenized
R11659 T15557 T15557 ROOT homogenized,homogenized
R11660 T15558 T15557 prep with,homogenized
R11661 T15559 T15561 det a,homogenizer
R11662 T15560 T15561 compound Polytron,homogenizer
R11663 T15561 T15558 pobj homogenizer,with
R11664 T15562 T15561 punct (,homogenizer
R11665 T15563 T15561 appos Kinematica,homogenizer
R11666 T15564 T15561 punct ),homogenizer
R11667 T15565 T15557 prep in,homogenized
R11668 T15566 T15565 pobj PBS,in
R11669 T15567 T15557 punct .,homogenized
R11670 T15568 T15570 amod Eight-fold,dilutions
R11671 T15569 T15570 amod serial,dilutions
R11672 T15570 T15575 nsubjpass dilutions,incubated
R11673 T15571 T15570 prep of,dilutions
R11674 T15572 T15573 compound lung,homogenates
R11675 T15573 T15571 pobj homogenates,of
R11676 T15574 T15575 auxpass were,incubated
R11677 T15575 T15575 ROOT incubated,incubated
R11678 T15576 T15575 prep on,incubated
R11679 T15577 T15578 compound MDCK,cells
R11680 T15578 T15576 pobj cells,on
R11681 T15579 T15575 prep for,incubated
R11682 T15580 T15581 nummod 5,days
R11683 T15581 T15579 pobj days,for
R11684 T15582 T15581 prep in,days
R11685 T15583 T15582 pobj DMEM,in
R11686 T15584 T15575 conj supplemented,incubated
R11687 T15585 T15584 prep with,supplemented
R11688 T15586 T15585 pobj trypsin,with
R11689 T15587 T15591 punct (,ml
R11690 T15588 T15589 nummod 1,µg
R11691 T15589 T15591 nmod µg,ml
R11692 T15590 T15591 compound /,ml
R11693 T15591 T15586 appos ml,trypsin
R11694 T15592 T15591 punct ),ml
R11695 T15593 T15586 punct ",",trypsin
R11696 T15594 T15596 nummod 2,L-glutamine
R11697 T15595 T15596 compound mM,L-glutamine
R11698 T15596 T15586 appos L-glutamine,trypsin
R11699 T15597 T15596 punct ",",L-glutamine
R11700 T15598 T15601 nummod 0.4,pyruvate
R11701 T15599 T15601 compound mM,pyruvate
R11702 T15600 T15601 compound sodium,pyruvate
R11703 T15601 T15596 appos pyruvate,L-glutamine
R11704 T15602 T15601 cc and,pyruvate
R11705 T15603 T15601 conj antibiotics,pyruvate
R11706 T15604 T15575 punct .,incubated
R11707 T15605 T15618 prep For,added
R11708 T15606 T15605 pobj read-out,For
R11709 T15607 T15618 punct ",",added
R11710 T15608 T15609 nummod 0.5,%
R11711 T15609 T15618 nsubjpass %,added
R11712 T15610 T15613 amod chicken,cells
R11713 T15611 T15613 amod red,cells
R11714 T15612 T15613 compound blood,cells
R11715 T15613 T15609 appos cells,%
R11716 T15614 T15615 punct (,RBC
R11717 T15615 T15613 appos RBC,cells
R11718 T15616 T15613 punct ),cells
R11719 T15617 T15618 auxpass were,added
R11720 T15618 T15618 ROOT added,added
R11721 T15619 T15618 cc and,added
R11722 T15620 T15618 conj end-point,added
R11723 T15621 T15625 nsubjpass dilution,monitored
R11724 T15622 T15621 prep of,dilution
R11725 T15623 T15622 pobj hemagglutination,of
R11726 T15624 T15625 auxpass was,monitored
R11727 T15625 T15618 conj monitored,added
R11728 T15626 T15625 punct .,monitored
R11729 T15627 T15628 nummod TCID50,titers
R11730 T15628 T15631 nsubjpass titers,calculated
R11731 T15629 T15631 auxpass were,calculated
R11732 T15630 T15631 advmod then,calculated
R11733 T15631 T15631 ROOT calculated,calculated
R11734 T15632 T15631 prep according,calculated
R11735 T15633 T15632 prep to,according
R11736 T15634 T15635 det the,method
R11737 T15635 T15633 pobj method,to
R11738 T15636 T15635 prep of,method
R11739 T15637 T15636 pobj Reed,of
R11740 T15638 T15637 cc and,Reed
R11741 T15639 T15640 compound Muench,[
R11742 T15640 T15637 conj [,Reed
R11743 T15641 T15642 nummod 85,]
R11744 T15642 T15635 appos ],method
R11745 T15643 T15631 punct .,calculated
R11565 T15463 T15464 amod Viral,infection
R11566 T15464 T15471 nsubj infection,adapted
R11567 T15465 T15464 cc and,infection
R11568 T15466 T15464 conj determination,infection
R11569 T15467 T15466 prep of,determination
R11570 T15468 T15469 amod viral,titers
R11571 T15469 T15467 pobj titers,of
R11572 T15470 T15471 nsubj Mouse,adapted
R11573 T15471 T15471 ROOT adapted,adapted
R11574 T15472 T15473 compound IAV,X-47
R11575 T15473 T15471 dobj X-47,adapted
R11576 T15474 T15475 punct (,H3N2
R11577 T15475 T15473 appos H3N2,X-47
R11626 T15524 T15523 cc and,lethal
R11627 T15525 T15523 conj sublethal,lethal
R11628 T15526 T15522 pobj infection,For
R11629 T15527 T15529 punct ",",received
R11630 T15528 T15529 nsubj mice,received
R11631 T15529 T15529 ROOT received,received
R11632 T15530 T15531 advmod respectively,2-LD50
R11633 T15531 T15534 amod 2-LD50,X-47
R11634 T15532 T15531 cc or,2-LD50
R11635 T15533 T15531 conj 0.05-LD50,2-LD50
R11636 T15534 T15529 dobj X-47,received
R11637 T15535 T15529 punct .,received
R11638 T15536 T15537 aux To,determine
R11639 T15537 T15551 advcl determine,measured
R11640 T15538 T15540 amod pulmonary,titers
R11641 T15539 T15540 amod viral,titers
R11642 T15540 T15537 dobj titers,determine
R11643 T15541 T15540 punct ",",titers
R11644 T15542 T15544 amod median,culture
R11645 T15543 T15544 compound tissue,culture
R11646 T15544 T15540 appos culture,titers
R11647 T15545 T15546 amod infectious,dose
R11648 T15546 T15540 appos dose,titers
R11649 T15547 T15546 punct (,dose
R11650 T15548 T15546 appos TCID50,dose
R11651 T15549 T15546 punct ),dose

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T15645 689-696 Protein denotes trypsin
T15644 119-123 Protein denotes MDCK